EAVI2020 Newsletter December 2020 (.pdf opens in a new window) 2020 has been a bumpy ride (to say the least) for everyone, including EAVI2020. Clinical trials had to come to a standstill due to lockdown restrictions ..
My name is Alessandra Gallinaro and I am a Postdoc Researcher at the Istituto Superiore di Sanità (ISS) in Rome, Italy. The road to my PhD Whilst studying Medical Biotechnology at “La Sapienza” University in R..
Time to meet: Dominik Damm Where I started I wished to work in the field of HIV vaccine research since I was 13 years old. When I started my study of biology at the University of Regensburg, I tried to get into all imm..
The EAVI2020 consortium smiled for a group shot. They met over two full mornings in November. Members presented work-package updates and future work. After four years of 80+ consortium members meeting together every y..
Postponed due to the global pandemic, 'HIV glycoprotein engineering for vaccines' will be virtual course as organised by EAVI2020 partners, Amsterdam University Medical Centre (AMC). After a few months delay due to COVI..
Download the August 2020 newsletter (.pdf). In this issue: EAVI2020 project extension HIVR4P 2021 goes virtual Students in focus: Isabella Huettner & Ehsan Suleiman EAVI2020 out and about Upcoming..
Time to meet: Ehsan Suleiman I am an employee of Polymun Scientific and a PhD student of Biomolecular Technology of Proteins (BioToP) at the University of Natural Resources and Life Sciences in Vienna, Austria. I have ..
Prof Hanke, EAVI2020 PI at the University of Oxford spoke to Scientia which included his work on T cell response to second-generation conserved immunogen, HIVconsvX, and its predecessor, HIVconsv. Scientia is a popularis..
Time to meet: Isabella Huettner [caption id="attachment_1391" align="alignleft" width="200"] Isabella Huettner is a PhD student at King’s College London, UK.[/caption] During the 4 years of my PhD with Dr Katie Doo..
Funding body, European Commission recognises blight of COVID-19 on Horizon2020 clinical research COVID-19 has had a considerable impact on the progress of EAVI2020’s clinical trial and lab work. Like many Horizon2020 ..